The Office of Technology Licensing was established in 1970 to transfer technologies developed at Stanford. Find out more about OTL's history, mission, staff, and statistics.

Login to TechFinder » 

If your browser is not displaying images correctly, try clearing your cookies and cache to solve the problem.

Login and Registration
You are not logged into the OTL TechFinder web site. If you are already registered, please login. Otherwise, registration is free and entitles you to receive emails and correspondence about new technology releases.

Would you like to find out about other ways to engage with Stanford?
If so, please visit http://corporate.stanford.edu/.

Repositioning Dasatinib, Atorvastatin, and BMS-936557 for treatment of transplant rejection

A team of Stanford researchers have discovered that Atorvastatin, Dasatinib, and BMS-936557 target core immune response genes and could be repositioned to treat acute organ transplant rejection. This work is based on identification of the targets through ...
more information »

Role of extracellular matrix proteins Hevin and SPARC in Central Nervous System Synapse Formation

Researchers at Stanford University have discovered that the activities of two proteins, hevin and SPARC, may be modulated to influence synapse formation in retinal ganglion cells (RGCs) and excitatory CNS neurons. While hevin induces the formation of thes...
more information »

What is TechFinder?
By clicking the links above you can search the database for opportunities and submit requests for additional information. TechFinder contains text and images. TechFinder is updated within minutes of any changes made at Stanford's Office of Technology Licensing.